Evidence map›Paper›PMID 24523941›Full record

ArticlePloS one2014

Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis.

Akiko Yusa, Makoto Toneri, Taisuke Masuda, Seiji Ito, Shuhei Yamamoto, Mina Okochi, Naoto Kondo, Hiroji Iwata, Yasushi Yatabe, Yoshiyuki Ichinosawa and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Technologies for Viable Circulating Tumor Cell Isolation.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Akiko YusaAichi Science and Technology Foundation, Knowledge Hub Aichi, Priority Research Projects, Japan ; Department of Micro-Nano Systems Engineering, Graduate School of Engineering, Nagoya University, Japan ; Division of Oncological Pathology, Aichi Cancer Center Research Institute, Japan.
Makoto ToneriDepartment of Gastrointestinal Surgery, Aichi Cancer Center Central Hospital, Japan ; Division of Oncological Pathology, Aichi Cancer Center Research Institute, Japan.
Taisuke MasudaDepartment of Micro-Nano Systems Engineering, Graduate School of Engineering, Nagoya University, Japan.
Seiji ItoDepartment of Gastrointestinal Surgery, Aichi Cancer Center Central Hospital, Japan.
Shuhei YamamotoDepartment of Biotechnogloy, Graduate School of Engineering, Nagoya University, Japan.
Mina OkochiDepartment of Biotechnogloy, Graduate School of Engineering, Nagoya University, Japan.
Naoto KondoDepartment of Breast Oncology, Aichi Cancer Center Central Hospital, Japan.
Hiroji IwataDepartment of Breast Oncology, Aichi Cancer Center Central Hospital, Japan.
Yasushi YatabeDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center Central Hospital, Japan.
Yoshiyuki IchinosawaOptnics Precision Co., Ltd., Japan.
Seichin KinutaOptnics Precision Co., Ltd., Japan.
Eisaku KondoDivision of Oncological Pathology, Aichi Cancer Center Research Institute, Japan.
Hiroyuki HondaDepartment of Biotechnogloy, Graduate School of Engineering, Nagoya University, Japan.
Fumihito AraiDepartment of Micro-Nano Systems Engineering, Graduate School of Engineering, Nagoya University, Japan.
Hayao NakanishiDivision of Oncological Pathology, Aichi Cancer Center Research Institute, Japan.
Aichi Cancer Center · JPNagoya University · JPAichi Science & Technology Foundation · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) in the blood of patients with epithelial malignancies provide a promising and minimally invasive source for early detection of metastasis, monitoring of therapeutic effects and basic research addressing the mechanism of metastasis. In this study, we developed a new filtration-based, sensitive CTC isolation device. This device consists of a 3-dimensional (3D) palladium (Pd) filter with an 8 µm-sized pore in the lower layer and a 30 µm-sized pocket in the upper layer to trap CTCs on a filter micro-fabricated by precise lithography plus electroforming process. This is a simple pump-less device driven by gravity flow and can enrich CTCs from whole blood within 20 min. After on-device staining of CTCs for 30 min, the filter cassette was removed from the device, fixed in a cassette holder and set up on the upright fluorescence microscope. Enumeration and isolation of CTCs for subsequent genetic analysis from the beginning were completed within 1.5 hr and 2 hr, respectively. Cell spike experiments demonstrated that the recovery rate of tumor cells from blood by this Pd filter device was more than 85%. Single living tumor cells were efficiently isolated from these spiked tumor cells by a micromanipulator, and KRAS mutation, HER2 gene amplification and overexpression, for example, were successfully detected from such isolated single tumor cells. Sequential analysis of blood from mice bearing metastasis revealed that CTC increased with progression of metastasis. Furthermore, a significant increase in the number of CTCs from the blood of patients with metastatic breast cancer was observed compared with patients without metastasis and healthy volunteers. These results suggest that this new 3D Pd filter-based device would be a useful tool for the rapid, cost effective and sensitive detection, enumeration, isolation and genetic analysis of CTCs from peripheral blood in both preclinical and clinical settings.

Indexed as

Neoplastic Cells, CirculatingAdultAnimalsCell Line, TumorCell SeparationCell SizeEquipment DesignErb-b2 Receptor Tyrosine KinasesGenes, rasHumansImaging, Three-DimensionalMaleMiceMice, NudeMiddle AgedNeoplasm MetastasisERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesPalladium

Identifiers

PMID24523941
PMCPMC3921253
OpenAlexW2068725790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.